In addition, an examination of the DPS data (shown in Figure S1) revealed links between lower STC1 expression and a more favorable outcome in patients with BLCA, CESC, GBM, HNSC, KIRP, LGG, LUAD, and STAD. This evidence concerns the gene STC1 and glioblastoma.